Literature DB >> 24975907

Invasive hemodynamic characterization of heart failure with preserved ejection fraction.

Mads J Andersen1, Barry A Borlaug2.   

Abstract

Recent hemodynamic studies have advanced our understanding of heart failure with preserved ejection fraction (HFpEF). Despite improved pathophysiologic insight, clinical trials have failed to identify an effective treatment for HFpEF. Invasive hemodynamic assessment can diagnose or exclude HFpEF, making it invaluable in understanding the basis of the disease. This article reviews the hemodynamic mechanisms underlying HFpEF and how they manifest clinically, discusses invasive hemodynamic assessment as a diagnostic tool, and explores how invasive hemodynamic profiling may allow understanding of pathophysiological differences and inform the design and entry criteria for future trials.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dyspnea; Heart failure with preserved ejection fraction; Invasive hemodynamic assessment

Mesh:

Year:  2014        PMID: 24975907     DOI: 10.1016/j.hfc.2014.03.001

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  18 in total

1.  Response to Letter Regarding Article, “Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction”.

Authors:  Barry A Borlaug; Horng Chen; Grace Lin; Margaret M Redfield; Gregory D Lewis; Marc J Semigran; Steven E McNulty; Martin LeWinter; Anita Deswal; Kenneth B Margulies
Journal:  Circ Heart Fail       Date:  2015-07       Impact factor: 8.790

Review 2.  Patient selection in heart failure with preserved ejection fraction clinical trials.

Authors:  Jacob P Kelly; Robert J Mentz; Alexandre Mebazaa; Adriaan A Voors; Javed Butler; Lothar Roessig; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor; Carolyn S P Lam
Journal:  J Am Coll Cardiol       Date:  2015-04-28       Impact factor: 24.094

3.  Chronic exercise training prevents coronary artery stiffening in aortic-banded miniswine: role of perivascular adipose-derived advanced glycation end products.

Authors:  An Ouyang; T Dylan Olver; Craig A Emter; Bradley S Fleenor
Journal:  J Appl Physiol (1985)       Date:  2019-07-11

4.  Haemodynamics of Heart Failure With Preserved Ejection Fraction: A Clinical Perspective.

Authors:  Mauro Gori; Attilio Iacovoni; Michele Senni
Journal:  Card Fail Rev       Date:  2016-11

Review 5.  Diastolic Stress Testing Along the Heart Failure Continuum.

Authors:  T Jake Samuel; Rhys Beaudry; Satyam Sarma; Vlad Zaha; Mark J Haykowsky; Michael D Nelson
Journal:  Curr Heart Fail Rep       Date:  2018-12

Review 6.  Heart failure with preserved ejection fraction and skeletal muscle physiology.

Authors:  Stephen D Farris; Farid Moussavi-Harami; April Stempien-Otero
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

7.  Periplocin Alleviates Cardiac Remodeling in DOCA-Salt-Induced Heart Failure Rats.

Authors:  Jiameng Hao; Liping Chang; Dandong Wang; Chuanyuan Ji; Shaolan Zhang; Yunlong Hou; Yiling Wu
Journal:  J Cardiovasc Transl Res       Date:  2022-05-26       Impact factor: 4.132

Review 8.  Evaluation and management of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Nat Rev Cardiol       Date:  2020-03-30       Impact factor: 32.419

9.  Clinical performance and exercise hemodynamics in patients with severe secondary tricuspid regurgitation and chronic atrial fibrillation.

Authors:  Jesper K Jensen; Tor S Clemmensen; Christian A Frederiksen; Joachim Schofer; Mads J Andersen; Steen H Poulsen
Journal:  BMC Cardiovasc Disord       Date:  2021-06-04       Impact factor: 2.298

10.  HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction.

Authors:  Markus Wallner; Deborah M Eaton; Remus M Berretta; Laura Liesinger; Matthias Schittmayer; Juergen Gindlhuber; Jichuan Wu; Mark Y Jeong; Ying H Lin; Giulia Borghetti; Sandy T Baker; Huaqing Zhao; Jessica Pfleger; Sandra Blass; Peter P Rainer; Dirk von Lewinski; Heiko Bugger; Sadia Mohsin; Wolfgang F Graier; Andreas Zirlik; Timothy A McKinsey; Ruth Birner-Gruenberger; Marla R Wolfson; Steven R Houser
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 19.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.